tiprankstipranks
Arcadia Biosciences (RKDA)
NASDAQ:RKDA
US Market

Arcadia Biosciences (RKDA) Earnings Dates, Call Summary & Reports

Compare
473 Followers

Earnings Data

Report Date
May 08, 2025
TBA Not Confirmed
Period Ending
2025 (Q1)
Consensus EPS Forecast
-0.98
Last Year’s EPS
-1.78
Same Quarter Last Year
Moderate Buy
Based on 1 Analysts Ratings
---

Earnings Call Summary

Earnings Call Date:Mar 20, 2025
|
% Change Since: 2.73%
|
Next Earnings Date:May 08, 2025
Earnings Call Sentiment|Positive
The earnings call highlights significant growth in Zola coconut water sales and successful business restructuring, signaling a positive trajectory for Arcadia. However, the decline in GLA oil sales and increased SG&A costs pose challenges. Overall, the positive aspects of Zola's performance and business refocusing outweigh the negatives.
Company Guidance
During the Arcadia Biosciences Fourth Quarter and Full Year 2024 Financial Results and Business Highlights Conference Call, the company provided guidance illustrating a successful year. Arcadia reported full-year revenues slightly over $5 million, with a gross profit of $2.1 million and gross margins of 41.3%. Despite a higher than anticipated quarterly run rate for R&D and SG&A expenses due to unforeseen transaction-related fees, the company demonstrated significant momentum. Zola coconut water products showcased impressive growth, with sales increasing 46% for the year and 124% in the fourth quarter alone compared to the previous year. This was achieved through expanded distribution, adding over 1,600 new stores, and growing retail distribution by 86%. Zola's growth outpaced the coconut water category by more than double, with gross margins consistent in the low to mid-30% range. Despite challenges, Arcadia maintained strong cash management, reducing operating cash use by 30% in the second half of 2024 compared to the first half, and ended the year with $4.2 million in cash. The call also mentioned ongoing efforts to monetize the remaining wheat intellectual property portfolio and provided updates on a pending transaction with Roosevelt Resources expected to conclude by the end of Q2 2025.
Zola Revenue Growth
Zola revenues increased 124% in Q4 2024 compared to the same period last year. For the full year, Zola sales increased by 46%, driven by significant distribution gains and an 86% growth in retail distribution.
Cash Management and Profitability
Operating cash use decreased by 30% in the second half of 2024 compared to the first half, indicating improved cash management. Gross margins were reported at 41.3% for the year, aligning with previous guidance.
Successful Business Restructuring
Arcadia successfully restructured its business by exiting underperforming Body Care brands and monetizing a portion of its wheat intellectual property portfolio, resulting in a leaner company focused on Zola coconut water products.
Strong Category Performance
Zola's growth outpaced the coconut water category by more than 2:1, with the category growing 18.5% while Zola increased by 38.5% for the full year.
---

Arcadia Biosciences (RKDA) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

RKDA Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
May 08, 20252025 (Q1)
-0.98 / -
-1.78
Mar 20, 20252024 (Q4)
-0.89 / -2.98
-2.1-41.90% (-0.88)
Nov 12, 20242024 (Q3)
-0.81 / -1.18
-1.8937.57% (+0.71)
Aug 13, 20242024 (Q2)
1.55 / 0.78
0.6127.87% (+0.17)
May 09, 20242024 (Q1)
-2.21 / -1.78
-7.79577.16% (+6.01)
Mar 28, 20242023 (Q4)
-2.58 / -2.10
-6.3166.72% (+4.21)
Nov 09, 20232023 (Q3)
-2.93 / -1.89
-4.860.63% (+2.91)
Aug 10, 20232023 (Q2)
-4.84 / 0.61
-6.8108.97% (+7.41)
May 11, 20232023 (Q1)
-6.60 / -7.79
-8.5919.27% (+0.80)
Mar 30, 20232022 (Q4)
-6.80 / -6.31
-16.862.44% (+10.49)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---

RKDA Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Mar 20, 2025$3.30$3.15-4.55%
Nov 12, 2024$4.24$4.19-1.18%
Aug 13, 2024$2.99$2.66-11.04%
May 09, 2024$2.08$2.06-0.96%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---

FAQ

When does Arcadia Biosciences (RKDA) report earnings?
Arcadia Biosciences (RKDA) is schdueled to report earning on May 08, 2025, TBA Not Confirmed.
    What is Arcadia Biosciences (RKDA) earnings time?
    Arcadia Biosciences (RKDA) earnings time is at May 08, 2025, TBA Not Confirmed.
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is RKDA EPS forecast?
          RKDA EPS forecast for the fiscal quarter 2025 (Q1) is -0.98.
            ---
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis